Results 231 to 240 of about 309,141 (294)

Racial, Ethnic, and Socioeconomic Survival Disparities in Early-Onset Metastatic Colorectal Cancer.

JAMA Netw Open
Wang JS, Johnson B, Murphy CC.
europepmc   +1 more source

Investigational CRISPR-Cas9-edited T cells for metastatic colorectal cancer treatment: Clinical insights for future development. [PDF]

Mol Ther Oncol
Lou E, Foo J, Leder K.
europepmc   +1 more source

Surgical Resection for Colorectal Liver Metastasis in Elderly Patients Aged ≥ 80: A Retrospective Nationwide Cohort Survey in Japan With Propensity Score Matching

Annals of Gastroenterological Surgery, EarlyView.
Surgical resection for CRLM seems to be as effective in elderly patients aged ≥ 80 as in nonelderly patients. However, elderly patients aged ≥ 80 had significantly worse cancer‐specific survival (CSS) and overall survival (OS). The significantly worse CSS and OS may have resulted from a lower rate of treatment for recurrence in elderly patients aged ...
Kiichi Sugimoto, Akio Saiura, Shuko Nojiri, Hirotoshi Kobayashi, Goro Honda, Kazushige Kawai, Kiyoshi Hasegawa, Keiichi Takahashi   +7 more
wiley   +1 more source

Retrospective Analysis of Regorafenib Efficiency in Treatment of Metastatic Colorectal Cancer-Experience of Two Polish Comprehensive Cancer Centers. [PDF]

J Clin Med
Grabiec M, Raźniewska D, Kałużewski T, Krakowska M, Radecka B, Potemski P.   +5 more
europepmc   +1 more source

Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: a systematic review and meta-analysis. [PDF]

J Gastrointest Oncol
Udaikumar J, Ingawale S, Nimmagadda R, Kuppili S, Lella VV, Suvvari TK, Cheloff A, Bellamkonda A, Giri S, Oberstein P, Shaukat A.   +10 more
europepmc   +1 more source

Delirium associated with trifluridine/tipiracil in an elderly patient with metastatic colorectal cancer: A case report. [PDF]

PCN Rep
Otani K, Kinoshita T, Shindo R, Shibuya N.   +3 more
europepmc   +1 more source

Angiogenesis in metastatic colorectal cancer: a bibliometric analysis of 5875 publications between 2000 and 2023. [PDF]

Discov Oncol
Xia Y, Yu C, Wang S, Chen Z, Yuan C, Li Y, Zhao X.   +6 more
europepmc   +1 more source

Association of RAS mutational status with clinical outcomes in metastatic colorectal cancer treated with trifluridine/tipiracil or regorafenib. [PDF]

Sci Rep
Hsieh MC, Rau KM, Liu KW, Chiu CC, Chen CI, Song LC, Chen HP.   +6 more
europepmc   +1 more source

A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer. [PDF]

Cancer Discov
Centonze A, Roura AJ, Novillo-Font M, Giordano C, Hernando-Momblona X, Llanses M, Prats P, Sevillano M, Cabot D, Novell M, Pabst G, Andersch F, Cañellas-Socias A, Zhang C, Giakoumakis NN, Sparks H, Dunsby C, Colombelli J, Fernández-Barral A, Sancho E, Stephan-Otto Attolini C, Muñoz A, Barbachano A, Palmer HG, Martínez-Quintanilla J, Zuber J, Blaj C, Quintana E, Cortina C, Marti-Renom MA, Batlle E.   +30 more
europepmc   +1 more source